Title:
MAGE-3遺伝子から誘導されてHLA-A1により提示される単離されたノナペプチドおよびそれらの用途
Document Type and Number:
Japanese Patent JP3608788
Kind Code:
B2
Abstract:
The invention involves a nonapeptide derived from the tumor rejection antigen precursor encoded by gene MAGE-3. This nonapeptide is presented by HLA molecules HLA-A1. The resulting complexes are identified by cytolytic T cells. Such recognition may be used in diagnostics, or therapeutically.
Inventors:
Boone-Farure, Thierry
Van der Brügen, Pierre
De Praen, Etienne
Rilkin, Christoph
Traversary, Katya
Van der Brügen, Pierre
De Praen, Etienne
Rilkin, Christoph
Traversary, Katya
Application Number:
JP50737394A
Publication Date:
January 12, 2005
Filing Date:
August 30, 1993
Export Citation:
Assignee:
Ludwig Institute for Cancer Research
International Classes:
G01N33/53; A61K35/16; A61K38/00; A61K39/395; A61P37/00; C07K1/00; C07K7/06; C07K7/08; C07K14/00; C07K14/47; C07K14/705; C07K16/28; C07K16/30; C07K17/00; C12N5/10; C12N5/12; C12N5/18; C12N15/09; C12N15/11; C12P21/02; C12P21/08; G01N33/574; G01N33/577; A61K39/00; (IPC1-7): C07K14/705; C07K7/06; C12N5/10; C12N15/09; G01N33/53; G01N33/574; G01N33/577
Domestic Patent References:
| JP6511144A |
Other References:
Immunogenetics,Vol.35(1992)p.145-152
J.Exp.Med.,Vol.176(1992.Nov.)p.1453-1457
J.Exp.Med.,Vol.176(1992.Nov.)p.1453-1457
Attorney, Agent or Firm:
Aoyama Aoi
Kyousei Tamura
Hiromitsu Takayama
Kyousei Tamura
Hiromitsu Takayama